Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.

Latest action: Reported out of Assembly Committee, 2nd Reading

Voted 6/23/2026View source

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

Docket history

9/28/2026Received in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
9/24/2026Passed by the Assembly (66-3-3)
6/23/2026Reported out of Assembly Committee, 2nd Reading
6/18/2026Reported out of Asm. Comm. with Amendments, and Referred to Assembly Appropriations Committee
1/13/2026Introduced, Referred to Assembly Health Committee